Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Raw Materials (2016 - 2022)

Usana Health Sciences (USNA) has disclosed Raw Materials for 12 consecutive years, with $24.6 million as the latest value for Q3 2022.

  • Quarterly Raw Materials fell 9.4% to $24.6 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $24.6 million through Jul 2022, down 9.4% year-over-year, with the annual reading at $30.3 million for FY2022, 6.89% up from the prior year.
  • Raw Materials for Q3 2022 was $24.6 million at Usana Health Sciences, down from $30.6 million in the prior quarter.
  • The five-year high for Raw Materials was $30.9 million in Q4 2021, with the low at $14.1 million in Q1 2020.
  • Average Raw Materials over 5 years is $23.6 million, with a median of $22.5 million recorded in 2019.
  • The sharpest move saw Raw Materials crashed 37.08% in 2020, then soared 93.29% in 2021.
  • Over 5 years, Raw Materials stood at $19.5 million in 2018, then decreased by 18.58% to $15.9 million in 2019, then skyrocketed by 42.13% to $22.6 million in 2020, then surged by 37.05% to $30.9 million in 2021, then decreased by 20.37% to $24.6 million in 2022.
  • According to Business Quant data, Raw Materials over the past three periods came in at $24.6 million, $30.6 million, and $30.3 million for Q3 2022, Q2 2022, and Q1 2022 respectively.